The National Academy of Sports Medicine (NASM) has launched a new course, “Understanding Weight Loss Medications” for fitness and wellness professionals to better serve clients on weight loss medications.
Being informed about the latest weight loss medications can give coaches and trainers a competitive edge, especially given recent findings from consumer insights firm CivicScience. A recent report from the firm revealed that one in five U.S. adults are either using or considering GLP-1s, with half planning to stay on the medications long-term or indefinitely.
NASM’s new online course covers the latest advancements in weight loss medications, including FDA-approved options and those in clinical trials. The course also covers the latest research on semaglutide and tirzepatide, their drug actions and potential side effects, and how fitness and wellness professionals can guide GLP-1 and GIP users toward long-term success.
“We recognize the growing prevalence of GLP-1/GIP medications in use by exercising populations and believe it’s imperative for fitness and wellness professionals to be well-informed about these drugs,” NASM head of product Mike Fantigrassi said. “Our new course provides the necessary knowledge and tools to ensure that professionals can offer comprehensive support, including exercise guidance tailored to the unique needs of clients on these medications. Understanding the interplay between GLP-1/GIP medications and exercise is crucial for fostering a safe and effective path towards sustainable health and wellness.”
Weight loss medications have quickly become apart of the wellness and longevity conversation. Telehealth platform Hims & Hers recently aired a spot during Super Bowl LIX advertising its affordable, U.S.-formulated weight loss medications and personalized treatment plans. Meanwhile, forward-thinking gyms have begun to integrate a weight loss medication component to its services, such as Recess Rx from Dallas-based Recess Fitness, F45 Training and Fitness Premier.
